Experienced in COVID-19

Dr. Luis I. De La Cruz

Sleep Medicine | Pulmonary Medicine | Intensive Care Medicine
Upstate Lung And Critical Care Specialists PC
151 Harold Fleming Ct, 
Spartanburg, SC 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Experienced in COVID-19
Upstate Lung And Critical Care Specialists PC
151 Harold Fleming Ct, 
Spartanburg, SC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Luis De La Cruz is a Sleep Medicine specialist and a Pulmonary Medicine provider in Spartanburg, South Carolina. Dr. De La Cruz is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Pleurisy, and Advanced Bronchoscopy. Dr. De La Cruz is currently accepting new patients.

His clinical research consists of co-authoring 4 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 1 clinical trial in the study of COVID-19.

Specialties
Sleep Medicine
Pulmonary Medicine
Intensive Care Medicine
Licenses
Sleep Medicine in SC
Hospital Affiliations
Spartanburg Medical Center
Cherokee Medical Center
Union Medical Center
Languages Spoken
English
Castilian
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

UPSTATE LUNG AND CRITICAL CARE SPECIALISTS PC
151 Harold Fleming Ct, Spartanburg, SC 29303

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
Enrollment Status: Recruiting
Publish Date: June 25, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
Enrollment Status: Completed
Publish Date: August 15, 2025
Intervention Type: Drug, Biological
Study Drug: Mepolizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
A Phase 2B, Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversing Ticagrelor in Subjects Aged 50 to 80 Years Old
A Phase 2B, Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversing Ticagrelor in Subjects Aged 50 to 80 Years Old
Enrollment Status: Completed
Publish Date: April 08, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
View 4 Less Clinical Trials

4 Total Publications

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
Journal: Science (New York, N.Y.)
Published: November 23, 2021
Similar Doctors
Gina M. Merritt
Advanced in COVID-19
Dr. Gina M. Merritt
Sleep Medicine | Intensive Care Medicine
Advanced in COVID-19
Dr. Gina M. Merritt
Sleep Medicine | Intensive Care Medicine

Atrium Health Pulmonology & Sleep Medicine

1010 E. Dixon Blvd., Suite A, 
Shelby, NC 
 (30.5 miles away)
980-487-2700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gina Merritt is a Sleep Medicine specialist and an Intensive Care Medicine provider in Shelby, North Carolina. Dr. Merritt is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are COVID-19, Lung Metastases, Obstructive Sleep Apnea, Gastrostomy, and Ureteroscopy. Dr. Merritt is currently accepting new patients.

Michael C. Dearment
Advanced in COVID-19
Dr. Michael C. Dearment
Sleep Medicine | Intensive Care Medicine
Advanced in COVID-19
Dr. Michael C. Dearment
Sleep Medicine | Intensive Care Medicine

Atrium Health Pulmonology & Sleep Medicine

1010 E. Dixon Blvd., Suite A, 
Shelby, NC 
 (30.5 miles away)
980-487-2700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Dearment is a Sleep Medicine specialist and an Intensive Care Medicine provider in Shelby, North Carolina. Dr. Dearment is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Lung Metastases, COVID-19, Chronic Obstructive Pulmonary Disease (COPD), Obstructive Sleep Apnea, and Gastrostomy. Dr. Dearment is currently accepting new patients.

Advanced in COVID-19
Dr. Sau Y. Wan
Pulmonary Medicine | Intensive Care Medicine
Advanced in COVID-19
Dr. Sau Y. Wan
Pulmonary Medicine | Intensive Care Medicine

Spartanburg Medical Center

101 E Wood St, 
Spartanburg, SC 
 (1.6 miles away)
864-560-6000
Languages Spoken:
English
See accepted insurances

Sau Wan is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Spartanburg, South Carolina. Dr. Wan is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are COVID-19, End-Stage Renal Disease (ESRD), Pneumonia, Gastrostomy, and Endoscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. De La Cruz's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 34 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile